查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600173

骨生技藥品市場：按產品、技術、加工方法、飼料材料、應用和最終用戶 - 2025-2030 年全球預測

Osteobiologics Market by Product, Technique, Processing Method, Material Sourced, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年骨生技藥品市場價值為12.9億美元，預計到2024年將達到13.6億美元，複合年成長率為5.47%，到2030年將達到18.8億美元。

骨生技藥品是更廣泛的生物材料市場的一個子集，包括促進骨癒合、再生和修復的產品。其中包括移植骨替代物、生長因子和細胞支架，它們在整形外科和牙科手術中發揮重要作用。骨質疏鬆症和骨關節炎等骨疾病盛行率的上升、人口老化以及外科手術的進步推動了對骨生技藥品的需求。主要應用包括脊椎融合手術、創傷融合術和自然癒合不足的重組手術。醫院、專科診所和研究機構是骨生技藥品產品的主要最終使用者。關鍵的市場開拓因素包括材料科學和生物工程的技術進步、研發投資的增加以及對微創手術技術的日益關注。更接近天然骨特性的合成骨移植物的開發以及客製化植入3D 列印技術的創新正在帶來機會。建議包括專注於開發強大的產品平臺來滿足未滿足的臨床需求，並尋求與醫療機構的策略夥伴關係以提高市場滲透率。然而，骨生技藥品的高成本、嚴格的法律規範以及免疫反應和排斥風險等挑戰限制了市場的成長。此外，與產品標準化相關的複雜性和漫長的核准時間阻礙了快速創新。為了克服這些障礙，公司應該投資於具有成本效益的製造技術並參與協作研發以簡化監管核准。這個市場競爭激烈，注重科學進步，並提高消費者對骨生技藥品益處的認知。結合生物和合成成分以產生卓越效果的生物活性材料和混合用途療法具有相當大的創新空間，並為市場擴張和差異化提供了利潤豐厚的途徑。

主要市場統計
基準年[2023] 12.9億美元
預測年份 [2024] 13.6億美元
預測年份 [2030] 18.8億美元
複合年成長率（%） 5.47%

市場動態：揭示快速發展的骨生技藥品市場的關鍵市場洞察

供需的動態交互作用正在改變骨生技藥品市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球老化人口不斷增加，骨骼相關疾病盛行率上升
    • 涉及骨骼和關節的外科手術需要先進的骨癒合解決方案的增加
    • 對微創治療的需求不斷成長
  • 市場限制因素
    • 臨床結果的變異性影響產品的可靠性和可接受性
  • 市場機會
    • 使用 3D 列印和組織工程開發針對患者的治療方法
    • 擴大產品線，納入新型材料和生物藥品組合，以提高功效
  • 市場問題
    • 意識淡薄，缺乏熟練的專業人員

波特五力：駕馭骨生技藥品市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解骨生技藥品市場的外部影響

外部宏觀環境因素在塑造骨生技藥品市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解骨生技藥品市場的競爭格局

對骨生技藥品市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣：骨生技藥品市場供應商的績效評估

FPNV定位矩陣是評估骨生技藥品市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製骨生技藥品市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對骨生技藥品市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著全球人口持續老化，骨骼相關疾病的發生率也上升。
      • 涉及骨骼和關節的外科手術正在增加，這產生了對先進骨癒合解決方案的需求
      • 對微創治療的需求不斷成長
    • 抑制因素
      • 影響產品可靠性和可接受性的臨床結果的變異性
    • 機會
      • 使用 3D 列印和組織工程開發針對患者的治療方法
      • 擴大產品線，包括新材料和生物藥品的組合，以提高功效
    • 任務
      • 意識淡薄，缺乏熟練的專業人員
  • 市場區隔分析
    • 產品：由於支持新骨生長的骨傳導特性，同種異體移植物的新用途
    • 應用：需要結合抗菌和再生特性來靶向骨感染疾病和腫瘤的骨生物解決方案
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章骨生技藥品市場：依產品

  • 介紹
  • 同種異體移植
  • 骨髓抽吸濃縮液
  • 骨形成蛋白
  • 去礦物質骨基質
  • 血漿蛋白
  • 生物性骨材
  • 黏性補充品產品

第7章骨生技藥品市場：依技術分類

  • 介紹
  • 生物陶瓷及複合材料
  • 可注射生物材料
  • 整形外科生物材料植入

第8章骨生技藥品市場：依加工方法分類

  • 介紹
  • 海水淡化
  • 礦化作用
  • 骨傳導性
  • 骨誘導

第9章骨生技藥品市場：依供應材料分類

  • 介紹
  • 自然的
  • 合成

第10章骨生技藥品市場：依應用分類

  • 介紹
  • 骨感染疾病和腫瘤
  • 牙科骨移植
  • 關節重組
  • 脊椎融合手術
  • 外傷和不癒合骨折

第11章骨骼生技藥品市場：依最終用戶分類

  • 介紹
  • 醫院
  • 研究/學術機構
  • 專科診所

第12章美洲生技藥品市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太骨生技藥品市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章歐洲、中東和非洲的骨生技藥品市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Biogennix 推出由牛膠原蛋白製成的 Agilon 手術基質
    • Biogennix 的 Agilon 和 Morpheus Small Double 產品已獲得 FDA 批准
    • 位於爾灣的 Biogenics 推出骨跨纖維基質以改善手術效果
  • 戰略分析和建議

公司名單

  • Advancells Diagnostics
  • Aetna Inc.
  • AlloSource
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Australian BIoTechnologies Pty Ltd
  • Baxter International Inc.
  • Biogennix, LLC.
  • CONMED Corporation
  • Exactech, Inc.（TPG Capital 為母公司）
  • Geistlich Pharma AG
  • Integra LifeSciences Holdings Corporation
  • KLS Martin Group
  • KNITPRO INTERNATIONAL
  • Medical Device Business Services, Inc.
  • Medtronic Plc
  • MTF Biologics
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Osiris Therapeutics, Inc.（被 Smith & Nephew 收購）
  • ROYAL BIOLOGICS
  • RTI Surgical Holdings, Inc.（被 Montagu Private Equity LLP 收購）
  • Stryker Corporation
  • SynerHeal Pharmaceuticals
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-036C5CF3B4C0

The Osteobiologics Market was valued at USD 1.29 billion in 2023, expected to reach USD 1.36 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 1.88 billion by 2030.

Osteobiologics, a subset of the broader biomaterials market, encompass products that promote bone healing, regeneration, and repair. These include bone graft substitutes, growth factors, and cellular scaffolds, playing crucial roles in orthopedic and dental surgeries. The demand for osteobiologics is driven by the rising prevalence of bone disorders such as osteoporosis and osteoarthritis, the growing aging population, and advancements in surgical procedures. Key applications lie in spinal fusion, trauma fixation, and reconstructive surgeries where natural bone healing is insufficient. Hospitals, specialized clinics, and research institutions comprise the primary end-users of osteobiologics products. Significant market growth factors include technological advancements in material science and bioengineering, increased investment in research and development, and a rising focus on minimally invasive surgical techniques. Opportunities are emerging from developing synthetic bone grafts that mimic natural bone properties more closely and innovations in 3D printing technology for customized implants. Recommendations include focusing on robust product pipeline development to address unmet clinical needs and pursuing strategic partnerships with healthcare institutions for enhanced market penetration. However, challenges such as the high cost of osteobiologic products, stringent regulatory frameworks, and the risk of immune response or rejection limit market growth. Furthermore, complexities related to product standardization and long approval timelines impede rapid innovation. To overcome these barriers, companies should invest in cost-effective manufacturing technologies and engage in collaborative R&D to streamline regulatory approvals. The nature of this market is highly competitive, with a strong emphasis on scientific advancement and increased consumer awareness about the benefits of osteobiologics. There is considerable scope for innovation in bioactive materials and mixed-use therapies combining biological and synthetic components for superior outcomes, presenting lucrative avenues for market expansion and differentiation.

KEY MARKET STATISTICS
Base Year [2023] USD 1.29 billion
Estimated Year [2024] USD 1.36 billion
Forecast Year [2030] USD 1.88 billion
CAGR (%) 5.47%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Osteobiologics Market

The Osteobiologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing aging population globally and rising prevalence of bone-related conditions
    • Rising surgical interventions involving bones and joints necessitating advanced bone healing solutions
    • Growing demand for minimally invasive treatments
  • Market Restraints
    • Variability in clinical outcomes affecting the credibility and acceptance of products
  • Market Opportunities
    • Development of patient-specific treatments using 3D printing and tissue engineering
    • Expansion of product lines to include novel materials and combinations of biological agents for enhanced efficacy
  • Market Challenges
    • Limited awareness and dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Osteobiologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Osteobiologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Osteobiologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Osteobiologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Osteobiologics Market

A detailed market share analysis in the Osteobiologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Osteobiologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Osteobiologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Osteobiologics Market

A strategic analysis of the Osteobiologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Osteobiologics Market, highlighting leading vendors and their innovative profiles. These include Advancells Diagnostics, Aetna Inc., AlloSource, Anika Therapeutics, Inc., Arthrex, Inc., Australian Biotechnologies Pty Ltd, Baxter International Inc., Biogennix, LLC., CONMED Corporation, Exactech, Inc.(parent company TPG Capital), Geistlich Pharma AG, Integra LifeSciences Holdings Corporation, KLS Martin Group, KNITPRO INTERNATIONAL, Medical Device Business Services, Inc., Medtronic Plc, MTF Biologics, NuVasive, Inc., Orthofix Medical Inc., Osiris Therapeutics, Inc. (acquired by Smith & Nephew), ROYAL BIOLOGICS, RTI Surgical Holdings, Inc.(acquired by Montagu Private Equity LLP), Stryker Corporation, SynerHeal Pharmaceuticals, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Osteobiologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, and Visco-Supplementation Products.
  • Based on Technique, market is studied across Bioceramics & Composites, Injectable Biomaterials, and Orthopedic Biomaterial Implants.
  • Based on Processing Method, market is studied across Demineralized, Mineralized, Osteoconductive, and Osteoinductive.
  • Based on Material Sourced, market is studied across Natural and Synthetic.
  • Based on Application, market is studied across Bone Infection & Tumors, Dental Bone Grafting, Joint Reconstruction, Spinal Fusion, and Trauma & Non-Union Fractures.
  • Based on End-User, market is studied across Hospitals, Research & Academic Institutes, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing aging population globally and rising prevalence of bone-related conditions
      • 5.1.1.2. Rising surgical interventions involving bones and joints necessitating advanced bone healing solutions
      • 5.1.1.3. Growing demand for minimally invasive treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Variability in clinical outcomes affecting the credibility and acceptance of products
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of patient-specific treatments using 3D printing and tissue engineering
      • 5.1.3.2. Expansion of product lines to include novel materials and combinations of biological agents for enhanced efficacy
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Emerging usage of allografts owing to their osteoconductive properties that support new bone growth
    • 5.2.2. Application: Need for osteobiologic solutions that combine antimicrobial and regenerative properties for targeting bone infection & tumors
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Osteobiologics Market, by Product

  • 6.1. Introduction
  • 6.2. Allografts
  • 6.3. Bone Marrow Aspirate Concentrate
  • 6.4. Bone Morphogenic Protein
  • 6.5. Demineralized Bone Matrices
  • 6.6. Plasma-Rich Protein
  • 6.7. Synthetic Orthobiologics
  • 6.8. Visco-Supplementation Products

7. Osteobiologics Market, by Technique

  • 7.1. Introduction
  • 7.2. Bioceramics & Composites
  • 7.3. Injectable Biomaterials
  • 7.4. Orthopedic Biomaterial Implants

8. Osteobiologics Market, by Processing Method

  • 8.1. Introduction
  • 8.2. Demineralized
  • 8.3. Mineralized
  • 8.4. Osteoconductive
  • 8.5. Osteoinductive

9. Osteobiologics Market, by Material Sourced

  • 9.1. Introduction
  • 9.2. Natural
  • 9.3. Synthetic

10. Osteobiologics Market, by Application

  • 10.1. Introduction
  • 10.2. Bone Infection & Tumors
  • 10.3. Dental Bone Grafting
  • 10.4. Joint Reconstruction
  • 10.5. Spinal Fusion
  • 10.6. Trauma & Non-Union Fractures

11. Osteobiologics Market, by End-User

  • 11.1. Introduction
  • 11.2. Hospitals
  • 11.3. Research & Academic Institutes
  • 11.4. Specialty Clinics

12. Americas Osteobiologics Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Osteobiologics Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Osteobiologics Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Biogennix launches Agilon Surgical Matrix made from bovine collagen
    • 15.3.2. Biogennix receives FDA clearance for Agilon and Morpheus Moldable products
    • 15.3.3. Irvine-based biogennix launches osteospan fiber matrix to enhance surgical outcomes
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advancells Diagnostics
  • 2. Aetna Inc.
  • 3. AlloSource
  • 4. Anika Therapeutics, Inc.
  • 5. Arthrex, Inc.
  • 6. Australian Biotechnologies Pty Ltd
  • 7. Baxter International Inc.
  • 8. Biogennix, LLC.
  • 9. CONMED Corporation
  • 10. Exactech, Inc.(parent company TPG Capital)
  • 11. Geistlich Pharma AG
  • 12. Integra LifeSciences Holdings Corporation
  • 13. KLS Martin Group
  • 14. KNITPRO INTERNATIONAL
  • 15. Medical Device Business Services, Inc.
  • 16. Medtronic Plc
  • 17. MTF Biologics
  • 18. NuVasive, Inc.
  • 19. Orthofix Medical Inc.
  • 20. Osiris Therapeutics, Inc. (acquired by Smith & Nephew)
  • 21. ROYAL BIOLOGICS
  • 22. RTI Surgical Holdings, Inc.(acquired by Montagu Private Equity LLP)
  • 23. Stryker Corporation
  • 24. SynerHeal Pharmaceuticals
  • 25. Wright Medical Group N.V.
  • 26. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. OSTEOBIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. OSTEOBIOLOGICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OSTEOBIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OSTEOBIOLOGICS MARKET DYNAMICS
  • TABLE 7. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MARROW ASPIRATE CONCENTRATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENIC PROTEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PLASMA-RICH PROTEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC ORTHOBIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY VISCO-SUPPLEMENTATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BIOCERAMICS & COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY INJECTABLE BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ORTHOPEDIC BIOMATERIAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MINERALIZED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY OSTEOCONDUCTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY OSTEOINDUCTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE INFECTION & TUMORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DENTAL BONE GRAFTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & NON-UNION FRACTURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 287. OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 288. OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023